HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the Microdosing market. Azopharma will provide services to synthesize material amenable to microdose studies as well as formulate, administer microdoses in a clinical environment and analyze samples. Microdosing is an important growing trend among pharmaceutical and regulatory agencies around the world. This technology enables the pharmaceutical industry to save both time and money on their development process by receiving early PK and ADME data in humans.